The impact of the intraoperative intact PTH monitoring and whole PTH monitoring on parathyroidectomy for hyperparathyroidism

The impact of the intraoperative intact PTH monitoring and whole PTH monitoring on parathyroidectomy for hyperparathyroidism - The impact of the intraoperative intact PTH monitoring and whole PTH monitoring on parathyroidectomy for hyperparathyroidism

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000045281

Enrollment

300

Registered

2021-08-28

Start date

2021-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperparathyroidism

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients who consent with the enrollment of this study.

Exclusion criteria

Exclusion criteria: The patients who do not consent with the enrollment of this study.

Design outcomes

Primary

Measure	Time frame
Intact PTH levels, whole PTH levels, calcium levels, phosphorus levels, kidney function, and liver function will be measured during perioperative period.	—

Secondary

Measure	Time frame
Intact PTH levels, whole PTH levels, calcium levels, phosphorus levels, kidney function, liver function, and reoperation due to persistent and recurrent hyperparathyroidism will be investigated within 5 years after operation.	—

Countries

Japan

Contacts

Public ContactTAKAHISA HIRAMITSU

Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital Transplant and Endocrine Surgery

thira@nagoya2.jrc.or.jp+81528321121

Outcome results